The Journal of Practical Medicine >
ANGPTL8 knockout reduces lipopolysaccharide⁃induced hepatic lipid deposition
Received date: 2023-10-20
Online published: 2024-05-15
Objective To study the influence of ANGPTL8 in lipopolysaccharide (LPS)?induced hepatic lipid deposition. Methods Male wild?type(WT) and ANGPTL8 knockout mice at 6-8 weeks were used to induce sepsis models by intrabitoneal injection of LPS (10 mg/kg). qPCR and immunofluorescence were used to detected the mRNA and protein expression of ANGPTL8 in liver tissue and HepG2 cells respectively; The contents of alanine aminotransferase (ALT), aspartate aminotransferase (AST) in serum and the triglyceride (TG) and malondialdehyde (MDA) in liver homogenate were detected by kits; the histopathological changes of liver tissue were analyzed through HE staining. Lipids accumulation in liver were detected by oil red O staining. The apoptosis of liver was determinated by TUNEL staining. RNA?seq was used to analyzing the differentially expressed genes in the liver tissue of WT and ANGPTL8 KO mice, and the qPCR and Western Blot were used to verify the differential expressed genes. Results The expression of ANGPTL8 in the liver was significantly upregulated at 48 hours after LPS stimulation. Compared with WT mice, the hepatic lipid deposition, steatosis, and apoptosis were significantly alleviated in liver of ANGPTL8 KO mice, the ALT and AST levels in serum and the TG and MDA content in liver homogenate of ANGPTL8 KO mice were also reduced significantly. The expression of caveolin?1(CAV1) in liver of ANGPTL8 KO mice was significantly higher than that of WT mice. Conclusions LPS promoted the expression and secretion of ANGPTL8 in liver tissue, and ANGPTL8 increased hepatic lipid deposition and peroxidation by inhibiting the expression of CAV1.
Key words: ANGPTL8; LPS; CAV1; lipid deposition; apoptosis
Shan LUO , Ying FENG , Dandan FAN , Wenxin ZHENG , Xingrong GUO , Xuzhi. RUAN . ANGPTL8 knockout reduces lipopolysaccharide⁃induced hepatic lipid deposition[J]. The Journal of Practical Medicine, 2024 , 40(9) : 1197 -1203 . DOI: 10.3969/j.issn.1006-5725.2024.09.004
| 1 | SRZI? I, NESEK A V, TUNJI? P D. SEPSIS DEFINITION: WHAT'S NEW IN THE TREATMENT GUIDELINES [J]. Acta Clin Croat, 2022, 61(): 67-72. doi:10.20471/acc.2022.61.s1.11 |
| 2 | ACKERMAN M H, AHRENS T, KELLY J, et al. Sepsis [J]. Crit Care Nurs Clin North Am, 2021, 33(4): 407-418. doi:10.1016/j.cnc.2021.08.003 |
| 3 | STRNAD P, TACKE F, KOCH A, et al. Liver - guardian, modifier and target of sepsis [J]. Nat Rev Gastroenterol Hepatol, 2017, 14(1): 55-66. doi:10.1038/nrgastro.2016.168 |
| 4 | KIMURA I, ICHIMURA A, OHUE-KITANO R, et al. Free Fatty Acid Receptors in Health and Disease [J]. Physiol Rev, 2020, 100(1): 171-210. doi:10.1152/physrev.00041.2018 |
| 5 | MUNIZ-SANTOS R, LUCIERI-COSTA G, DE ALMEIDA M A P, et al. Lipid oxidation dysregulation: an emerging player in the pathophysiology of sepsis [J]. Front Immunol, 2023, 14: 1224335. doi:10.3389/fimmu.2023.1224335 |
| 6 | AREFANIAN H, AL-KHAIRI I, KHALAF N A, et al. Increased expression level of ANGPTL8 in white adipose tissue under acute and chronic cold treatment [J]. Lipids Health Dis, 2021, 20(1): 117. doi:10.1186/s12944-021-01547-0 |
| 7 | ZHANG Z, YUAN Y, HU L, et al. ANGPTL8 accelerates liver fibrosis mediated by HFD-induced inflammatory activity via LILRB2/ERK signaling pathways [J]. J Adv Res, 2023, 47: 41-56. doi:10.1016/j.jare.2022.08.006 |
| 8 | 高玉玖, 胡蓉, 方晨, 等. ANGPTL8敲除减轻DEN诱导的小鼠急性肝损伤 [J]. 实用医学杂志, 2023, 39(3): 278-284. doi:10.3969/j.issn.1006-5725.2023.03.003 |
| 9 | GAO Y, YUAN Y, WEN S, et al. Dual role of ANGPTL8 in promoting tumor cell proliferation and immune escape during hepatocarcinogenesis [J]. Oncogenesis, 2023, 12(1): 26. doi:10.1038/s41389-023-00473-3 |
| 10 | FERNANDEZ-ROJO M A, RAMM G A. Caveolin-1 Function in Liver Physiology and Disease [J]. Trends Mol Med, 2016, 22(10): 889-904. doi:10.1016/j.molmed.2016.08.007 |
| 11 | BOSMANN M, WARD P A. The inflammatory response in sepsis [J]. Trends immunol, 2013, 34(3): 129-136. doi:10.1016/j.it.2012.09.004 |
| 12 | YAN J, LI S, LI S. The role of the liver in sepsis [J]. Int Rev Immunol, 2014, 33(6): 498-510. doi:10.3109/08830185.2014.889129 |
| 13 | KUBES P, JENNE C. Immune Responses in the Liver [J]. Ann Rev Immunol, 2018, 36: 247-277. doi:10.1146/annurev-immunol-051116-052415 |
| 14 | KIM T S, CHOI D H. Liver Dysfunction in Sepsis [J]. Korean J Gastroenterol, 2020, 75(4):182-187. doi:10.4166/kjg.2020.75.4.182 |
| 15 | THOMAS H. Sepsis: Bile acids promote inflammation in cholestasis-associated sepsis [J]. Nat Rev Gastroenterol Hepatol, 2017, 14(6): 324-325. doi:10.1038/nrgastro.2017.55 |
| 16 | VANDEWALLE J, LIBERT C. Sepsis: a failing starvation response [J]. Trends Endocrinol Metab, 2022, 33(4): 292-304. doi:10.1016/j.tem.2022.01.006 |
| 17 | WASYLUK W, NOWICKA-ST??KA P, ZWOLAK A. Heart Metabolism in Sepsis-Induced Cardiomyopathy-Unusual Metabolic Dysfunction of the Heart [J]. Int J Environ Res Public Health, 2021, 18(14):7598. doi:10.3390/ijerph18147598 |
| 18 | EYENGA P, REY B, EYENGA L, et al. Regulation of Oxidative Phosphorylation of Liver Mitochondria in Sepsis [J]. Cells, 2022, 11(10):1598. doi:10.3390/cells11101598 |
| 19 | HOU K, LI S, ZHANG M, et al. Caveolin-1 in autophagy: A potential therapeutic target in atherosclerosis [J]. Clin Chim Acta, 2021, 513: 25-33. doi:10.1016/j.cca.2020.11.020 |
| 20 | FRANK P G, PAVLIDES S, CHEUNG M W, et al. Role of caveolin-1 in the regulation of lipoprotein metabolism [J]. Am J Physiol Cell Physiol, 2008, 295(1) :C242-C248. doi:10.1152/ajpcell.00185.2008 |
| 21 | KARHAN A N, ZAMMOURI J, AUCLAIR M, et al. Biallelic CAV1 null variants induce congenital generalized lipodystrophy with achalasia [J]. Eur J Endocrinol, 2021, 185(6): 841-854. doi:10.1530/eje-21-0915 |
| 22 | XUE W, WANG J, JIANG W, et al. Caveolin-1 alleviates lipid accumulation in NAFLD associated with promoting autophagy by inhibiting the Akt/mTOR pathway [J]. Eur J Pharmacol, 2020, 871: 172910. doi:10.1016/j.ejphar.2020.172910 |
| 23 | RAZANI B, COMBS T P, WANG X B, et al. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities [J]. J Biol Chem, 2002, 277(10): 8635-8647. doi:10.1074/jbc.m110970200 |
/
| 〈 |
|
〉 |